Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

574
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
574
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

405
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
405
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

381
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
381
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

363
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
363
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

132
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
132
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

354
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
354

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bayesian adaptive randomization in the I-SPY2 sequential multiple assignment randomized trial.

Biometrics·2026
Same author

Perspectives from Sri Lankan physicians on current approaches to diagnosing and managing lower respiratory tract infections.

BMC research notes·2026
Same author

mHealth adherence in pediatric epilepsy: Outcomes of a sequential, multiple assignment, randomized trial (SMART).

Epilepsia·2026
Same author

Improving In-person Interpreter Utilization in Complex Care: Findings from a Stepped-Wedge Cluster Randomized Trial of Integrated Artificial Intelligence.

Journal of general internal medicine·2026
Same author

Longitudinal changes in haemoglobin, iron stores, and inflammatory markers following surgery and in critical illness: an analysis from the Practical Anaemia Bundle for Sustained Blood Recovery randomised clinical trial.

British journal of anaesthesia·2025
Same author

Independent Increments and Group Sequential Tests.

Statistics in medicine·2025

Related Experiment Videos

Q- and A-learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Phillip J Schulte1, Anastasios A Tsiatis2, Eric B Laber3

  • 1Biostatistician, Duke Clinical Research Institute, Durham, North Carolina 27701, USA ( phillip.schulte@duke.edu ).

Statistical Science : a Review Journal of the Institute of Mathematical Statistics
|January 27, 2015
PubMed
Summary

This study explores dynamic treatment regimes for sequential medical decisions. Q- and A-learning methods are detailed to find optimal treatment strategies for improved patient outcomes.

Keywords:
Advantage learningbias-variance tradeoffmodel misspecificationpersonalized medicinepotential outcomessequential decision making

Related Experiment Videos

Area of Science:

  • Biostatistics
  • Clinical Informatics
  • Health Services Research

Background:

  • Physicians make sequential treatment decisions based on patient data.
  • Dynamic treatment regimes provide sequential decision rules for clinical practice.
  • Estimating optimal regimes aims to maximize patient outcomes.

Purpose of the Study:

  • To provide a detailed account of Q- and A-learning methods.
  • To study the performance of these methods for estimating optimal dynamic treatment regimes.
  • To illustrate the application of these methods using a depression study dataset.

Main Methods:

  • Q-learning: an adaptive control algorithm for decision making.
  • A-learning: an alternative approach for estimating optimal treatment policies.
  • Application of both methods to real-world clinical data.

Main Results:

  • Comparative performance analysis of Q- and A-learning.
  • Demonstration of regime estimation using a depression study.
  • Insights into the effectiveness of sequential decision-making strategies.

Conclusions:

  • Q- and A-learning are valuable tools for estimating optimal dynamic treatment regimes.
  • These methods can guide clinical practice towards improved patient outcomes.
  • Further research can refine these approaches for complex diseases.